These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Is there a role for circulating tumor cells in the management of breast cancer? Hayes DF; Smerage J Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576 [TBL] [Abstract][Full Text] [Related]
65. Failed evidence of tumour cell removal from salvaged blood after leucocyte depletion. Hansen E Transfus Med; 2006 Jun; 16(3):213-4; author reply 215-6. PubMed ID: 16764603 [No Abstract] [Full Text] [Related]
66. The clinical significance of circulating tumor cells. Pantel K; Alix-Panabières C Nat Clin Pract Oncol; 2007 Feb; 4(2):62-3. PubMed ID: 17259923 [No Abstract] [Full Text] [Related]
67. Methods for detection of circulating tumour cells and their clinical value in cancer patients. Mikulová V; Kološtová K; Zima T Folia Biol (Praha); 2011; 57(4):151-61. PubMed ID: 21978757 [TBL] [Abstract][Full Text] [Related]
68. Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Poli M; Camargo A; Villa L; Moura R; Colella R; Deheinzelin D Vox Sang; 2008 Nov; 95(4):308-12. PubMed ID: 19138260 [TBL] [Abstract][Full Text] [Related]
69. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Budd GT Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916 [TBL] [Abstract][Full Text] [Related]
70. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733 [TBL] [Abstract][Full Text] [Related]
72. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Mostert B; Sleijfer S; Foekens JA; Gratama JW Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375 [TBL] [Abstract][Full Text] [Related]
73. Cancer micrometastasis and tumour dormancy. Wikman H; Vessella R; Pantel K APMIS; 2008; 116(7-8):754-70. PubMed ID: 18834417 [TBL] [Abstract][Full Text] [Related]
74. Looking forward in diagnostic pathology: the molecular superhighway. Abati A; Liotta LA Cancer; 1996 Jul; 78(1):1-3. PubMed ID: 8646703 [No Abstract] [Full Text] [Related]
75. Osteotropic cancers: from primary tumor to bone. Buijs JT; van der Pluijm G Cancer Lett; 2009 Jan; 273(2):177-93. PubMed ID: 18632203 [TBL] [Abstract][Full Text] [Related]
76. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR. Shen C; Hu L; Xia L; Li Y Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237 [TBL] [Abstract][Full Text] [Related]
77. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393 [TBL] [Abstract][Full Text] [Related]
78. Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative--letter. Attard G; Crespo M; Lim AC; Pope L; Zivi A; de Bono JS Clin Cancer Res; 2011 May; 17(9):3048-9; author reply 3050. PubMed ID: 21536548 [No Abstract] [Full Text] [Related]
79. PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma. Brownhill SC; Burchill SA Pract Lab Med; 2017 Apr; 7():41-44. PubMed ID: 28856217 [TBL] [Abstract][Full Text] [Related]
80. Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: a review. Pantel K; Ahr A Nucl Med Commun; 1998 Jun; 19(6):521-7. PubMed ID: 10234655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]